Cannabis was once a legal part of the pharmacopeia until sociopolitical factors led to its prohibition in the 20th century. The classification of cannabis as a Schedule I substance lacks scientific backing and reflects a significant shift in societal attitudes rather than medical evidence. Insights into how potential rescheduling could impact research and patient access are explored, highlighting the ongoing debate surrounding cannabis and its medicinal value.
